Methoden vergleichen
Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.
| Functional Assessment of Cancer Therapy-Breast (FACT-B)× | Functional Living Index-Cancer (FLIC)× | |
|---|---|---|
| Fachgebiet | Onkologische Pflege | Onkologische Pflege |
| Familie | Process / pipeline | Process / pipeline |
| Entstehungsjahr≠ | 1997 | 1984 |
| Urheber≠ | Marilyn Brady and David Cella | Henning Schipper |
| Typ≠ | Patient self-report disease-specific QoL instrument | Patient self-report functional living and quality-of-life scale |
| Wegweisende Quelle≠ | Brady, M. J., Cella, D. F., Mo, F., et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15(3), 974–986. DOI ↗ | Schipper, H., Clinch, J., & Olweny, C. L. M. (1996). Quality of life studies: definitions and conceptual issues. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 11–23). Lippincott-Raven. link ↗ |
| Aliasnamen | FACT-B, FACT-Breast | FLIC, Functional Living Index–Cancer |
| Verwandt | 4 | 4 |
| Zusammenfassung≠ | The FACT-B is a comprehensive 36-item disease-specific quality-of-life instrument that integrates the generic FACT-G (27 items covering physical, social, emotional, and functional well-being) with a 9-item breast-cancer-specific subscale addressing body image, sexual function, arm symptoms, and treatment side effects. Developed by Brady et al. in 1997, the FACT-B is the gold-standard QoL measure for breast cancer research and clinical practice, used in hundreds of clinical trials and enabling comparison across breast cancer populations and treatment modalities. | The Functional Living Index-Cancer is a 22-item patient self-report instrument that measures health-related quality of life in cancer patients across physical, social, emotional, and overall QoL domains. Developed by Schipper and colleagues in the mid-1980s, the FLIC was among the first disease-specific QoL instruments for cancer and served as a foundational model for subsequent comprehensive measures like the EORTC QLQ-C30, bridging early generic QoL concepts with cancer-specific measurement. |
| ScholarGateDatensatz ↗ |
|
|